PDE-5 inhibitors in selected herbal supplements from the Ghanaian market for better erectile function as tested by a bioassay

被引:10
作者
Akuamoa, Felicia [1 ,2 ,3 ]
Hoogenboom, Ron L. A. P. [3 ]
Hamers, Astrid [3 ]
Rietjens, Ivonne M. C. M. [1 ]
Bovee, Toine F. H. [3 ]
机构
[1] Wageningen Univ & Res, Div Toxicol, POB 8000, NL-6700 EA Wageningen, Netherlands
[2] Ghana Atom Energy Commiss, Appl Radiat Biol Ctr, POB AE 1, Atomic, Accra, Ghana
[3] Wageningen Food Safety Res, Akkermaalsbos 2, NL-6708 WB Wageningen, Netherlands
关键词
Screening; Phosphodiesterase assay; Herbal supplement; PDE-5; inhibitors; DIETARY-SUPPLEMENTS; SEXUAL DYSFUNCTION; UNITED-STATES; PREVALENCE; ANALOGS;
D O I
10.1016/j.tiv.2021.105130
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Herbal supplements sold as ?all natural? on various markets in Accra (Ghana) and advertised as highly efficacious in treating erectile dysfunction (ED) were bought and analysed by a PDE-5 enzyme inhibition assay. The claimed efficacy of these products could be the result of inherent plant constituents, but also of intentionally added pharmaceuticals. Medically, ED is treated with potent inhibitors of the phosphodiesterase-5 (PDE-5) enzyme, as in the case of sildenafil. To test the efficacy of the Ghanaian supplements, extracts were made and tested using a PDE-Glo phosphodiesterase assay, a luminescent high-throughput screening (HTS) method. Results revealed that about 90% of the selected samples were able to inhibit PDE-5 activity to a high extent. Estimated concentrations in sildenafil equivalents ranged from traces to very high, with 25 samples (62.5%) pointing at daily doses higher than 25 mg sildenafil equivalents and 9 (22.5%) of these at doses higher than the maximal recommended daily intake of 100 mg sildenafil equivalents. Further investigations are needed to confirm if the observed effects are due to inherent plant constituents or merely the result of added synthetic PDE5 enzyme inhibitors, especially because doses above 100 mg sildenafil equivalents per day may result in severe health risks.
引用
收藏
页数:7
相关论文
共 22 条
[1]   Nitrates as an Integral Part of Optimal Medical Therapy and Cardiac Rehabilitation for Stable Angina: Review of Current Concepts and Therapeutics [J].
Boden, William E. ;
Finn, Aloke V. ;
Patel, Dharmesh ;
Peacock, W. Frank ;
Thadani, Udho ;
Zimmerman, Franklin H. .
CLINICAL CARDIOLOGY, 2012, 35 (05) :263-271
[2]   Priapism: Pathogenesis, Epidemiology, and Management [J].
Broderick, Gregory A. ;
Kadioglu, Ates ;
Bivalacqua, Trinity J. ;
Ghanem, Hussein ;
Nehra, Ajay ;
Shamloul, Rany .
JOURNAL OF SEXUAL MEDICINE, 2010, 7 (01) :476-500
[3]  
Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53
[4]  
Danquah C. A., 2011, Advances in Applied Science Research, V2, P350
[5]   Recreational Use of Erectile Dysfunction Medications in Undergraduate Men in the United States: Characteristics and Associated Risk Factors [J].
Harte, Christopher B. ;
Meston, Cindy M. .
ARCHIVES OF SEXUAL BEHAVIOR, 2011, 40 (03) :597-606
[6]   Sexual dysfunction: Overview of prevalence, etiological factors, and treatments [J].
Heiman, JR .
JOURNAL OF SEX RESEARCH, 2002, 39 (01) :73-78
[7]   Erectile dysfunction and hypertension [J].
Kloner, R. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (03) :296-302
[8]  
Kotta Sabna, 2013, Pharmacogn Rev, V7, P1, DOI 10.4103/0973-7847.112832
[9]   Sexual dysfunction in the United States - Prevalence and predictors [J].
Laumann, EO ;
Paik, A ;
Rosen, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (06) :537-544
[10]   Definitions/Epidemiology/Risk Factors for Sexual Dysfunction [J].
Lewis, Ronald W. ;
Fugl-Meyer, Kerstin S. ;
Corona, Giovanni ;
Hayes, Richard D. ;
Laumann, Edward O. ;
Moreira, Edson D., Jr. ;
Rellini, Alessandra H. ;
Segraves, Taylor .
JOURNAL OF SEXUAL MEDICINE, 2010, 7 (04) :1598-1607